February 10, 2020 / 1:43 PM / 17 days ago

BRIEF-Rezolute Initiates Phase 2b Clinical Trial Of Lead Candidate RZ358 In Congenital Hyperinsulinism

Feb 10 (Reuters) - Rezolute Inc:

* REZOLUTE INITIATES PHASE 2B CLINICAL TRIAL OF LEAD CANDIDATE RZ358 IN CONGENITAL HYPERINSULINISM

* REZOLUTE INC - EXPECTS TO MAKE SIGNIFICANT ENROLLMENT PROGRESS TO ENABLE ATTAINMENT OF MID-STUDY RESULTS OVER COMING YEAR Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below